Personalizing the MDD Treatment Journey: Putting Patient-Centered Care Into Practice

CME Activities

Can You Provide Individualized Care to These Patients With Depression? Virtual Case Challenges

Medscape Education Psychiatry & Mental Health, December 2022

Can you recognize residual symptoms of depression in your patients? Sharpen your skills and expand your toolbox to individualize treatment

1.00 CME

1.00 ABIM MOC

1.00 CE

1.00 CE

Resources

Clinical Articles

Telepsychiatry and the coronavirus disease 2019 pandemic -- current and future outcomes of the rapid virtualization of psychiatric care.
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Comparative benefits and harms of antidepressant, psychological, complementary, and exercise treatments for major depression: an evidence report for a clinical practice guideline from the American College of Physicians
Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: a clinical practice guideline from the American College of Physicians

Patient Education

Personalizing Your Depression Treatment Journey

Steering Committee

Rakesh Jain, MD, MPH

Steering Committee Chair

Has disclosed the following relevant financial relationships:

Served as an advisor or consultant for: Abbvie, Allergan, Acadia, Adamas, Alfasignma, Cingulate Therapeutics, Eisai, Evidera, Impel, Janssen, Lilly, Lundbeck, Merck, Neos Therapeutics, Neurocrine Biosciences, Osmotica, Otsuka, Pamlab, Pfizer, Sage Therapeutics, Shire, Sunovion, Supernus, Takeda, Teva

Served as a speaker or a member of a speakers bureau for: Abbvie (Allergan), Alkermes, Corium, Indivior, Intra-Cellular Therapies, Ironshore Pharmaceuticals, Janssen, Lilly, Lundbeck, Merck, Neos Therapeutics, Neurocrine, Otsuka, Pamlab, Pfizer, Shire, Sunovion, Takeda, Teva, Tris Pharmaceuticals

Received grants for clinical research from: Abbvie (Allergan), Lilly, Lundbeck, Otsuka, Pfizer, Shire, Takeda

Denise Vanacore, ANP-BC, CRNP, PhD, PMHNP-BC

Steering Committee Chair

Has disclosed the following relevant financial relationships:

Served as a speaker or a member of a speakers bureau for: Abbvie

Anita H. Clayton, MD

Steering Committee Member

Has disclosed the following relevant financial relationships:

Served as an advisor or consultant for: Acadia, Alkermes, Allergan, AMAG Pharmaceuticals, Astellas, Fabre-Kramer, Janssen Research & Development, MindCure, Ovoca Bio, Praxis Precision Medicines, PureTech Health, S1 Biopharma, Sage Therapeutics, Takeda/Lundbeck, Vella Bioscience, WCG MedAvante-Prophase

Received grants for clinical research from: Dare Bioscience, Janssen, Relmada Therapeutics, Sage Therapeutics, Praxis Precision Medicines

Owns stock, stock options, or bonds from: Euthymics, Mediflix, S1 Biopharma

Larry Culpepper, MD, MPH

Steering Committee Member

Has disclosed the following relevant financial relationships:

Served as an advisor or consultant for: AbbVie Pharmaceuticals, Acadia Pharmaceuticals, Allergan Pharmaceuticals, Eisai Pharmaceuticals, Supernus Pharmaceuticals, Inc., Takeda Pharmaceuticals

Owns stock, stock options, or bonds from: M-3 Information

Sarah T Melton, PharmD, BCPP, BCACP, CGP, FASCP

Steering Committee Member

Disclosure: Sarah T Melton, PharmD, BCPP, BCACP, CGP, FASCP, has disclosed no relevant financial relationships.

Sagar Parikh, MD

Steering Committee Member

Has disclosed the following relevant financial relationships:

Served as an advisor or consultant for: Takeda, Lundbeck, Otsuka, Sage, Aifred, Mensante, Assurex (Myriad)

Received grants for clinical research from: Takeda, Aifred, Sage, Assurex

Owns stock, stock options, or bonds from: Mensante